Imatinib Mesylate in Treating Patients With Myelofibrosis

NCT00245128 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
10
Enrollment
OTHER
Sponsor class

Stopped Per PI, results from another similar study were published prior to study analysis. Negative study results were published therefore analysis was not completed

Conditions

Interventions

Sponsor

OHSU Knight Cancer Institute

Collaborators